WILMINGTON, N.C., Aug. 26 /PRNewswire-FirstCall/ -- aaiPharma
(Nasdaq: AAII) announced today the availability of a new web page at
http://www.aaipharma.com devoted to IMS Pipeline Monthly Supply Index information
regarding wholesaler channel inventory levels of 14 small to mid cap specialty
pharmaceutical companies, including aaiPharma, for the last 12 months.
This new component of the corporate web site is designed to provide
information reported by IMS about current and past trends in inventory levels,
and provide a context based on actual IMS data for the overall discussion in
the marketplace regarding trends in inventory levels in the specialty pharma
sector.
About aaiPharma
aaiPharma Inc. is a leading, science-based specialty pharmaceutical
company with corporate headquarters in Wilmington, North Carolina. With more
than 23 years of drug development expertise and a proven sales and marketing
track record, the Company is focused on acquiring, improving and marketing
well-known, branded medicines in pain management, gastroenterology and
critical care. In addition to its branded product portfolio and robust
pipeline, aaiPharma continues to offer comprehensive drug development services
to the pharmaceutical, biotechnology, generic and device industries through
its services division, AAI Development Services. For more information, please
visit aaiPharma's website at http://www.aaipharma.com.
SOURCE aaiPharma Inc.
 back to top
Related links:
http://www.aaipharma.com
CONTACT:
media, Andrea L. Johnston, Vice President,
Corporate Communications, +1-910-254-7340, or investors, James B.
Sloan, Jr., Senior Vice President, Corporate Finance,
+1-910-254-7690, both of aaiPharma Inc.
|
